Noul Co. Ltd. (376930) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Noul Co. Ltd. (376930:KRX), powered by AI.

Current Price
₩819
P/E Ratio
-2.1
Market Cap
42.0B
Sector
Healthcare
What is the Noul Co. Ltd. stock price forecast?

Noul Co. Ltd. is currently trading at ₩819. View real-time AI analysis on Alpha Lenz.

What is Noul Co. Ltd. insider trading activity?

View the latest insider trading data for Noul Co. Ltd. on Alpha Lenz.

What is Noul Co. Ltd.'s P/E ratio?

Noul Co. Ltd.'s P/E ratio is -2.1.

Noul Co. Ltd.

KRX · 376930
₩819+4(+0.49%)Market closedKRX regular session 09:00–15:30 KST
Ask about Noul Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Noul Co. Ltd. trades at a P/E of -2.1 (undervalued) with modest ROE of -87.0%. 3Y revenue CAGR of 111.4% highlights clear growth momentum.

Ask for details

Company Overview

Noul Co. Ltd. specializes in the development and provision of cutting-edge diagnostic and life science solutions. At the heart of its operations is the focus on molecular diagnostic technologies aimed at enhancing the efficiency and effectiveness of point-of-care testing. The company is recognized for its contributions to sectors including healthcare, research, and pharmaceuticals, providing critical tools and instruments that aid in the detection and monitoring of various diseases. By integrating advanced technology with user-friendly platforms, Noul is pivotal in streamlining diagnostic processes and improving patient outcomes. Its market presence underscores the growing demand for innovative diagnostic solutions in an increasingly health-conscious global environment. Founded on a mission to revolutionize diagnostic science, Noul Co. Ltd. plays a significant role in the medical device industry, contributing to advancements that support preventive healthcare and personalized medicine.

CEO임찬양(단독 대표이사)
SectorHealthcare
IndustryDiagnostics & Research
Employees139

Company Statistics

FY 2025

Profile

₩42,007,593,537Market Cap
₩5,121,885,650Revenue
51.29MShares Out
139Employees

Margins

8.18%Gross
-338.67%EBITDA
-392.03%Operating
-389.60%Pre-Tax
-389.60%Net

Valuation

-2.11P/E
1.64P/B
8.20EV/Sales
-2.79EV/EBITDA
-1.79P/FCF

Growth (CAGR)

111.43%Rev 3Yr
76.95%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-51.81%ROA
-87.04%ROE
-50.51%ROIC

Financial Health

₩656,290,170Cash & Cash Equivalents
₩12,886,271,950Net Debt
52.73%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Noul Co. Ltd. (ticker: 376930) is a company listed on KRX in the Healthcare sector (Diagnostics & Research). It has approximately 139 employees. Market cap is $42.0B.

The current price is ₩819 with a P/E ratio of -2.11x and P/B of 1.64x.

ROE is -87.04% and operating margin is -392.03%. Annual revenue is $5.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Noul Co. Ltd. (376930) Stock Forecast 2026 ₩819 — Price, Financials & Analyst Targets | Alpha Lenz